Global spread of carbapenem-resistant Acinetobacter baumannii
Journal of Antimicrobial Chemotherapy2009Vol. 65(2), pp. 233–238
Citations Over TimeTop 1% of 2009 papers
Abstract
The global dissemination of eight carbapenem-resistant lineages illustrates the success this organism has had in epidemic spread. The acquired OXA enzymes are widely distributed but are not the sole carbapenem resistance determinant in A. baumannii.
Related Papers
- → Cation Concentration Variability of Four Distinct Mueller-Hinton Agar Brands Influences Polymyxin B Susceptibility Results(2012)64 cited
- → Influence of testing methodology on the tigecycline activity profile against presumably tigecycline-non-susceptible Acinetobacter spp.(2009)46 cited
- Colistin and Polymyxin B Minimal Inhibitory Concentrations Determined by Etest Found Unreliable for Gram-Negative Bacilli.(2017)
- → Assessment of Ceftazidime-Avibactam 30/20-μg Disk, Etest versus Broth Microdilution Results When Tested against Enterobacterales Clinical Isolates(2022)10 cited
- → Evaluating vancomycin susceptibility in <em>Staphylococcus aureus</em>(2016)